Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double‐blind, controlled trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|48|3|E107-E116

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.48, Iss.3, 2018-02, pp. : E107-E116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment to “Antithrombin III administration for portal vein thrombosis in patients with liver disease: A randomized double‐blind controlled trial”

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E379-E380

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled trial of pridopidine in Huntington's disease

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1407-1415

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 329-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Perioperative immunonutrition in patients undergoing liver transplantation: A randomized double‐blind trial

By  

HEPATOLOGY, Vol. 61, Iss. 2, 2015-02 ,pp. : 639-647

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of high‐dose pravastatin in hypercholesterolemic patients with well‐compensated chronic liver disease: Results of a prospective, randomized, double‐blind, placebo‐controlled, multicenter trial

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1453-1463

John Wiley & Sons Inc

Access to resources Recommend Favorite